Onset acquires rights to acne med Clindagel
The acne medication Clindagel (clindamycin phosphate 1 percent) topical gel is now owned by Onset Dermatologics, according to a news release.
New Data Support Delgocitinib for Sensitive Skin Areas
Daily Derm Times: July 2, 2025
New Research Highlights Zabalafin Hydrogel's Novel Multi-Targeted Approach to AD Treatment
E-Learning Boosts OCT Training for BCC Detection